First Functionalized MRI Contrast Agent Recognizing Vascular Lesions

Analytical Sciences

Volumn 20, Issue 1, 2004, Pages 5-7

  Yamamoto, Tatsuhiro ^a   Ikuta, Kenjiro ^a   Oi, Keiji ^b   Abe, Kohtaro ^b   Uwatoku, Toyokazu ^b   Murata, Masaharu ^a   Shigetani, Noboru ^c   Yoshimitsu, Kengo ^b   Shimokawa, Hiroaki ^b   Katayama, Yoshiki ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM COMPOUNDS;

CONTRAST AGENT; DIETHYLENETRIAMINE; FUNCTIONALIZED; GD COMPLEXES; MRI CONTRAST AGENTS; PORCINE AORTA; VASCULAR ENDOTHELIUM; VASCULAR LESIONS;

MAGNETIC RESONANCE IMAGING;

CONTRAST MEDIUM; EVANS BLUE; GADOLINIUM PENTETATE; N TERT BUTOXYCARBONYL 2,2' DIMETHYLBENZIDINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AORTA; ARTICLE; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

EID: 9144257232     PISSN: 09106340     EISSN: None     Source Type: Journal    
DOI: 10.2116/analsci.20.5     Document Type: Article

References (9)

1. R. Ross, Nature, 1993, 362, 801.
2. X. Yu, S. K. Song, J. Chen, M. J. Scott, R. J. Fuhrhop, C. S. Hall, P. J. Gaffney, S. A. Wickline, and G. M. Lanza, Magn. Reson. Med., 2000, 44, 867.
3. H. Maaheimo, R. Renkonen, J. Turunen, L. Penttila, and O. Renkonen, Eur. J. Biochem., 1995, 234, 616.
4. M. Lewin, N. Carlesso, C. H. Tung, X. W. Tang, D. Cory, D. T. Scadden, and R. Weissleder, Nature Biotech., 2000, 18, 410.
5. H. R. Wabinga, East Afr. Med. J., 1996, 73, S19.
6. J. R. Woods, Jr. and H. Maibach, Obstet. Gynecol., 1979, 53, 602.
7. N. A. Dezutter, R. M. Sciot, T. J. de Groot, G. M. Bormans, and A. M. Verbruggen, Nucl. Med. Commun., 2001, 22, 553.
8. B. C. Christensen, J. Chemnitz, and I. Tkocz, Acta Pathol. Microbiol. Scand.: A, 1976, 84, 355.
9. S. Citi, J. Cell. Biol., 1993, 121, 485.